The Clearity Foundation Has Joined OCRA

Together, we’re expanding support, education, and resources for the gynecologic cancer community.

Two women pose for a photo. One rests her head on the other's shoulder. Both are smiling.

Strengthening Support Through Partnership

Ovarian Cancer Research Alliance (OCRA), the world’s leading ovarian and gynecologic cancer nonprofit, is proud to announce that The Clearity Foundation has combined with OCRA. This important development brings together two of the most respected organizations in the ovarian cancer field, combining OCRA’s leading research, advocacy, and patient support programs with Clearity’s focus on scientific education and support for women and families facing an ovarian cancer diagnosis.

Please explore the resources below to learn more about the expanded support and tools now available.

For Patients

Find essential information here about ovarian cancer prevention, risk factors, and steps to take if you’ve been newly diagnosed, in treatment or navigating life beyond.

Support & Resources

OCRA is here for you and your family to answer questions or connect you with resources to help you and offer support.

Research

OCRA has awarded more than 400 grants and invested $128 million in ovarian cancer and related gynecologic cancer research initiatives, becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world.

Advocacy

OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community, having helped secure $3.8 billion in federal research and education funding since inception..

Get Involved

Help us get one step closer to a cure. There are so many ways to lend a hand and improve the lives of patients and families impacted by ovarian and all gynecologic cancers.

About

OCRA is the leading organization in the world fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families.